Navigation Links
Simulation reveals how body repairs balance after damage
Date:9/25/2007

ATLANTA (September 25, 2007) Your body goes to a lot of trouble to make sure you stay upright. But when the brains neural pathways are impaired through injury, age or illness, muscles are deprived of the detailed sensory information they need to perform the constant yet delicate balancing act required for normal movement and standing.

With an eye towards building robots that can balance like humans, researchers at Georgia Tech and Emory University have created a computer simulation that sheds new light on how the nervous system reinvents its communication with muscles after sensory loss. The findings could someday be used to better diagnose and rehabilitate patients with balance problems (through normal aging or diseases such as Multiple Sclerosis or Parkinsons) by retraining their muscles and improving overall balance. The research will be published in the October issue of Nature Neuroscience.

The ultimate goal of rehabilitation is for patients to find the best way to adapt to their particular deficit. This system may help predict what the optimum combination of muscle and nerve activity looks like for each patient, helping patients and doctors set realistic goals and speeding recovery, said Lena Ting, lead researcher on the project and an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.

In a body without balance impairment, the nervous system collects sensory information from all over the body (skin, ears, feet, arms, eyes, etc.) and transmits this information to the muscles that control balance. When that information changes through the introduction of something like a strong wind, a raised crack in the pavement or an accidental bump from a nearby stranger, the nervous system sends the new information to the muscles and they adjust accordingly to maintain the bodys balance.

Impairments and injuries to the nervous system or the senses that report to
'/>"/>

Contact: Megan McRainey
megan.mcrainey@icpa.gatech.edu
404-894-6016
Georgia Institute of Technology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. MSI releases moleculizer - a new approach to simulation of intracellular biochemical networks
2. Large-scale Computer Simulations Reveal New Insights Into Antibiotic Resistance
3. NYU chemists use computer simulation to enhance understanding of DNA transcription
4. Sensor web simulation investigates technique to improve prediction of pollution across the globe
5. Largest computational biology simulation mimics life’s most essential nanomachine
6. Computer simulation hints at new HIV drug target
7. Virginia Techs System X supercomputer provides super tool for simulation of cell division
8. Simulations unravel outer membrane transport mechanism
9. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
10. A bacterial genome reveals new targets to combat infectious disease
11. Needling Chromosomes Reveals Cell Division Secret

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ADELPHIA, NOVEMBER 9, 2009 A nutritionist whose ...etables to the federal Women, Infants and Children...s Agnes Higgins Award for outstanding achievement ...il Harrison, Ph.D., MNS, , a professor in the Depa...ity of California, Los Angeles School of Public He...
(Date:11/8/2009)...HEALTH EDUCATION DESIGNED FOR ADULTS WITH INTELLEC...VES , An Indiana University study involving adu...adults increased their personal health knowledge a..., Adults with ID, an internationally accepted ter...es of obesity, physical inactivity and preventable...
(Date:11/6/2009)...-dwelling ants generally live in harmony with thei...hen they run out of space in their trees of choice...s. , The research, published in the November iss...ocument that ants bore into live trees, and it reo...tween ants and plants. , Ants and certain specie...
Breaking Biology News(10 mins):March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Ants are friendly to some trees, but not others 2Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 1Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 2Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 3Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 1Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 1Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 3Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 4
... in German . , DNA, the molecule that acts as ... life, is highly resistant against alteration by u...for its photostability presents some puzzling prob...four chemical bases that make up the DNA molecule....showing that DNA strands differ in their light sen...
...tion to the IOF World Congress on Osteoporosis 200...until October 31, 2008. , To benefit from lower ...www.iofbonehealth.org/wco/2008/homepage.html . Sp...ants from non-OECD countries and for IOF members. ...at higher rates, will be possible. , Your chance...
..., Inc. (Nasdaq:,AWRE), a leading supplier of broad...led a conference call to discuss the company,s ope...ursday, October 23, 2008, at 5:00 p.m.,Eastern Tim...st the,earnings conference call., This call is be...Investor Relations page of our website at http://...
Other Biology News:Can genetic information be controlled by light? 2Aware Announces Q3 2008 Earnings Conference Call 2
(Date:11/6/2009)...NNA, Austria, November 6 EUCODIS B...facturing, and marketing enzymes for the,chemical ...a research,agreement with Bio Sidus, the leading b... The agreement gives EUCODIS Bioscience exclusi...- to Bio Sidus, proprietary collection of,psychrop...
(Date:11/6/2009)..., Calif., Nov. 6 Intarcia Therapeu...s ITCA 650 (DUROS® continuous delivery of exe...es at the Ninth Annual Diabetes Technology Meeting...wscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,...Via ITCA 650 Lowers Plasma Glucose, HbA1c and Redu...
(Date:11/5/2009)...TON, Colo., Nov. 5 The endangered ...the western U.S. This rare carnivore feeds on pra... to plague and often entire population die-offs in...e (FWS) has implemented a ferret breeding program ...to their formerly native habitat. Unfortunately, ...
(Date:11/5/2009)...nce Call on Thursday, November 5, 2009 at 4:30 p.m...v. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceut...: OGXI ) today reported unaudited financial resul...tember 30, 2009 and reviewed the Company,s highlig...wing consolidated results reflect the operations o...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...XEL International Corporation (Nasdaq: PRXL ), a...r, will address important industry issues at the D...Meeting, being held from March 23 - 25, 2009 in Be...rs will present on topics ranging from global bios...mbination products, and clinical process validatio...
...stCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ:...results for the fourth quarter and year ended Dece...les results in our Medical Products Business and w... new technology initiatives despite a challenging ...t and CEO of Angiotech. "Not only did we increase ...
...nd AMSTERDAM, March 5 ,Agendia, a world leader in ...appointment of Dr. Albert A. (Al) Luderer to its S...30 years of experience in in vitro medical,diagnos...ent. Currently, he,is the Chief Executive Officer ...y using innovative platform technologies to dramat...
Other Biology Technology:PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 2PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 3PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 4PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 5Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 2Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 3Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 4Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 5Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 6Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 7Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 8Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 9Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 10Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 11Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 12Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 13Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 14Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 15Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 16Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 17Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 18Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 19Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 20Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 21Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 22Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 23Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 24Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 25Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 26Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 27Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 28Agendia Appoints Seasoned Diagnostics Executive Albert A. Luderer to Supervisory Board 2
AC1 Auto System, BioChemi™ Camera from UVP
Rabbit Anti-Pendrin (H-195) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
GeneAmp AccuRT RNA PCR Kit with Controls from Applied Biosystems
Mouse Anti-Human HLA-DRbeta Monoclonal Antibody, Unconjugated, Clone DA2 from Santa Cruz Biotechnology, Inc.
Biology Products: